Mirae Asset Global Investments’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-31,526
| Closed | -$876K | – | 2663 |
|
|
2024
Q1 | $876K | Sell |
31,526
-4,837
| -13% | -$134K | ﹤0.01% | 1609 |
|
|
2023
Q4 | $1.54M | Buy |
36,363
+2,117
| +6% | +$89.8K | ﹤0.01% | 1382 |
|
|
2023
Q3 | $748K | Buy |
34,246
+358
| +1% | +$7.82K | ﹤0.01% | 1682 |
|
|
2023
Q2 | $1.08M | Buy |
33,888
+1,116
| +3% | +$35.5K | ﹤0.01% | 1525 |
|
|
2023
Q1 | $799K | Buy |
32,772
+7,963
| +32% | +$194K | ﹤0.01% | 1662 |
|
|
2022
Q4 | $782K | Buy |
24,809
+2,162
| +10% | +$68.2K | ﹤0.01% | 1638 |
|
|
2022
Q3 | $640K | Buy |
22,647
+6,970
| +44% | +$197K | ﹤0.01% | 1729 |
|
|
2022
Q2 | $414K | Buy |
+15,677
| New | +$414K | ﹤0.01% | 1845 |
|